476 related articles for article (PubMed ID: 33407745)
1. How we treat mature B-cell neoplasms (indolent B-cell lymphomas).
Lumish M; Falchi L; Imber BS; Scordo M; von Keudell G; Joffe E
J Hematol Oncol; 2021 Jan; 14(1):5. PubMed ID: 33407745
[TBL] [Abstract][Full Text] [Related]
2. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous primary B-cell lymphomas: from diagnosis to treatment.
Lima M
An Bras Dermatol; 2015; 90(5):687-706. PubMed ID: 26560215
[TBL] [Abstract][Full Text] [Related]
4. Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.
Saleh K; Michot JM; Schernberg A; Lazarovici J; Chahine C; Danu A; Khalife-Saleh N; Rossignol J; Ghez D; Martin V; Mazeron R; Fermé C; Boros A; Ribrag V; Girinsky T
Cancer Med; 2020 Jun; 9(11):3725-3732. PubMed ID: 32249547
[TBL] [Abstract][Full Text] [Related]
5. B-cell non-Hodgkin lymphomas.
Silkenstedt E; Salles G; Campo E; Dreyling M
Lancet; 2024 May; 403(10438):1791-1807. PubMed ID: 38614113
[TBL] [Abstract][Full Text] [Related]
6. Management of indolent B-cell Lymphomas: A review of approved and emerging targeted therapies.
Smyth E; Cheah CY; Seymour JF
Cancer Treat Rev; 2023 Feb; 113():102510. PubMed ID: 36634434
[TBL] [Abstract][Full Text] [Related]
7. Are we nearing an era of chemotherapy-free management of indolent lymphoma?
Bachy E; Salles G
Clin Cancer Res; 2014 Oct; 20(20):5226-39. PubMed ID: 25320372
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, pathology and treatment of non-follicular indolent lymphomas.
Landgren O; Tilly H
Leuk Lymphoma; 2008; 49 Suppl 1():35-42. PubMed ID: 18821431
[TBL] [Abstract][Full Text] [Related]
9. Pathology of indolent B-cell neoplasms other than follicular lymphoma.
Sakata S; Tsuyama N; Takeuchi K
J Clin Exp Hematop; 2014; 54(1):11-22. PubMed ID: 24942942
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?
Fanale M
Hematology Am Soc Hematol Educ Program; 2013; 2013():406-13. PubMed ID: 24319212
[TBL] [Abstract][Full Text] [Related]
11. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
12. Indolent lymphomas of mature B lymphocytes.
Kurtin PJ
Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
[TBL] [Abstract][Full Text] [Related]
13. Marginal zone-related neoplasms of splenic and nodal origin.
Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
[TBL] [Abstract][Full Text] [Related]
14. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
15. Targeting indolent non-Hodgkin lymphoma.
Leslie LA; Skarbnik AP; Bejot C; Stives S; Feldman TA; Goy AH
Expert Rev Hematol; 2017 Apr; 10(4):299-313. PubMed ID: 28277849
[TBL] [Abstract][Full Text] [Related]
16. Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.
Lange J; Lenz G; Burkhardt B
Expert Rev Hematol; 2017 Feb; 10(2):123-135. PubMed ID: 27936978
[TBL] [Abstract][Full Text] [Related]
17. Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review.
Rivero A; Mozas P; Magnano L; López-Guillermo A
Front Oncol; 2023; 13():1170394. PubMed ID: 37207160
[TBL] [Abstract][Full Text] [Related]
18. Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.
van den Brand M; Scheijen B; Hess CJ; van Krieken JHJ; Groenen PJTA
Blood Rev; 2017 Nov; 31(6):426-435. PubMed ID: 28802906
[TBL] [Abstract][Full Text] [Related]
19. [Indolent lymphomas: classification, clinical presentation and treatment]].
Zenhäusern R
Praxis (Bern 1994); 2013 Mar; 102(7):399-406. PubMed ID: 23531907
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
